| Literature DB >> 35723640 |
Liyi Chen1, Chong Liu1, Zhen Ye1, Shengsheng Huang1, Tuo Liang1, Hao Li1, Jiarui Chen1, Wuhua Chen1, Hao Guo1, Tianyou Chen1, Yuanlin Yao1, Jie Jiang1, Xuhua Sun1, Ming Yi1, Shian Liao1, Chaojie Yu1, Shaofeng Wu1, Binguang Fan1, Xinli Zhan1.
Abstract
Background: The purpose of this study was to predict the surgical site infection risk after spinal tuberculosis surgery based on a nomogram. Patients andEntities:
Keywords: nomogram; risk factors; spinal tuberculosis; surgical site infection
Mesh:
Year: 2022 PMID: 35723640 PMCID: PMC9398487 DOI: 10.1089/sur.2022.042
Source DB: PubMed Journal: Surg Infect (Larchmt) ISSN: 1096-2964 Impact factor: 1.853
General Information of Patients in the Surgical Site and Non-Surgical Site Infection Groups
| | Non-surgical site infection | Surgical site infection | Overall |
|---|---|---|---|
| ( | ( | ( | |
| Gender | |||
| Female | 131 (41%) | 21 (28%) | 152 (39%) |
| Male | 187 (59%) | 55 (72%) | 242 (61%) |
| BMI | 20.0 ± 2.55 | 20.1 ± 3.18 | 20.06 ± 2.68 |
| Weight loss (kg) | 2.33 ± 3.28 | 1.91 ± 3.09 | 2.25 ± 3.24 |
| ODI | 18.1 ± 8.70 | 16.1 ± 5.89 | 17.69 ± 8.26 |
| VAS | 7.37 ± 1.53 | 7.17 ± 1.27 | 7.33 ± 1.48 |
| Age | 49.7 ± 18.0 | 47.1 ± 15.7 | 49.22 ± 17.63 |
| Occupation | |||
| Non-farmer | 121 (38%) | 31 (41%) | 152 (39%) |
| Farmer | 197 (62%) | 45 (59%) | 242 (61%) |
| Race | |||
| Non-Han | 156 (49%) | 38 (50%) | 194 (49%) |
| Han | 162 (51%) | 38 (50%) | 200 (51%) |
| Days before surgery (d) | 5.23 ± 5.65 | 4.54 ± 3.23 | 5.09 ± 5.27 |
| Systolic blood pressure (mm Hg) | 127 ± 19.9 | 126 ± 18.1 | 126.47 ± 19.54 |
| Diastolic blood pressure (mm Hg) | 78.9 ± 11.4 | 77.1 ± 12.1 | 78.56 ± 11.57 |
| Pain | |||
| No | 22 (7%) | 1 (1%) | 23 (6%) |
| Yes | 296 (93%) | 75 (99%) | 371 (94%) |
| Lower limb pain | |||
| No | 149 (47%) | 37 (49%) | 186 (47%) |
| Yes | 169 (53%) | 39 (51%) | 208 (53%) |
| Number of lower limbs with pain | 0.925 ± 0.923 | 0.842 ± 0.895 | 0.91 ± 0.92 |
| Fatigue | |||
| No | 221 (69%) | 57 (75%) | 278 (71%) |
| Yes | 97 (31%) | 19 (25%) | 116 (29%) |
| Fever | |||
| No | 225 (71%) | 58 (76%) | 283 (72%) |
| Yes | 93 (29%) | 18 (24%) | 111 (28%) |
| Night sweats | |||
| No | 243 (76%) | 60 (79%) | 303 (77%) |
| Yes | 75 (24%) | 16 (21%) | 91 (23%) |
| Appetite | |||
| No | 132 (42%) | 25 (33%) | 157 (40%) |
| Yes | 186 (58%) | 51 (67%) | 237 (60%) |
| Medical history (mo) | 9.21 ± 17.3 | 6.12 ± 7.27 | 8.61 ± 15.89 |
| ASIA | |||
| A | 3 (1%) | 0 (0%) | 3 (1%) |
| B | 6 (2%) | 0 (0%) | 6 (2%) |
| C | 25 (8%) | 2 (3%) | 27 (7%) |
| D | 76 (24%) | 16 (21%) | 92 (23%) |
| E | 208 (65%) | 58 (76%) | 266 (68%) |
| JOA | 18.1 ± 6.21 | 18.9 ± 4.36 | 18.24 ± 5.90 |
BMI = body mass index; ODI = Oswestry Disability Index; VAS = visual analogue scale; ASIA = American Spinal Injury Association; JOA = Japanese Orthopedic Association.
Laboratory Test Results of the Patients in the Surgical Site Infection and Non-Surgical Site E Groups
| | Non-surgical site infection | Surgical site infection | Overall |
|---|---|---|---|
| ( | ( | ( | |
| Blood glucose (mmol/L) | 5.32 ± 1.39 | 5.03 ± 1.11 | 5.27 ± 1.35 |
| Blood type | |||
| A | 61 (19%) | 14 (18%) | 75 (19%) |
| B | 80 (25%) | 23 (30%) | 103 (26%) |
| AB | 18 (6%) | 6 (8%) | 24 (6%) |
| O | 159 (50%) | 33 (43%) | 192 (49%) |
| C-reactive protein (mg/L) | 26.8 ± 35.1 | 38.7 ± 51.3 | 29.07 ± 38.98 |
| Hepatitis B surface antigen | |||
| Negative | 285 (90%) | 68 (89%) | 353 (90%) |
| Positive | 33 (10%) | 8 (11%) | 41 (10%) |
| White blood cells (*109/L) | 7.16 ± 2.56 | 7.66 ± 3.42 | 7.24 ± 2.73 |
| Hemoglobin (g/L) | 121 ± 16.0 | 118 ± 19.2 | 120.76 ± 16.72 |
| Platelets (*109/L) | 308 ± 100 | 311 ± 115 | 308.43 ± 103.25 |
| Percentage of neutrophils (%) | 0.625 ± 0.115 | 0.643 ± 0.150 | 0.63 ± 0.12 |
| Percentage of lymphocytes (%) | 0.242 ± 0.104 | 0.217 ± 0.110 | 0.24 ± 0.11 |
| Absolute monocytes (*109/L) | 0.651 ± 0.273 | 0.667 ± 0.260 | 0.65 ± 0.27 |
| Percentage of monocytes (%) | 0.0994 ± 0.0672 | 0.0933 ± 0.0312 | 0.098 ± 0.062 |
| Total bilirubin (mcmol/L) | 8.33 ± 7.57 | 8.37 ± 9.75 | 8.34 ± 8.02 |
| Direct bilirubin (mcmol/L) | 3.49 ± 3.87 | 3.97 ± 6.27 | 3.58 ± 4.43 |
| Indirect bilirubin (mcmol/L) | 4.86 ± 4.09 | 4.41 ± 3.75 | 4.77 ± 4.02 |
| Total protein (g/L) | 70.7 ± 7.81 | 69.7 ± 7.13 | 70.5 ± 7.69 |
| Albumin (g/L) | 38.7 ± 4.65 | 36.9 ± 4.61 | 38.33 ± 4.69 |
| AST (U/L) | 25.9 ± 19.0 | 25.5 ± 22.9 | 25.83 ± 19.75 |
| ALT (U/L) | 23.7 ± 22.3 | 23.9 ± 24.4 | 23.74 ± 22.66 |
| AST/ALT | 1.50 ± 2.13 | 1.32 ± 0.629 | 1.47 ± 1.93 |
| Blood uric acid (mcmol/L) | 399 ± 183 | 405 ± 151 | 399.95 ± 177.42 |
| Erythrocyte sedimentation rate (mm/h) | 40.3 ± 27.8 | 39.8 ± 24.4 | 40.22 ± 27.13 |
| Blood creatinine (mcmol/L) | 70.1 ± 47.7 | 64.3 ± 14.5 | 68.99 ± 43.40 |
| Blood urea (mmol/L) | 4.44 ± 2.00 | 4.84 ± 2.43 | 4.52 ± 2.09 |
AST = aspartate aminotransferase; ALT = alanine aminotransferase.
Surgical Information of the Patients in the Surgical Site Infection and Non-Surgical Site Infection Groups
| | Non-surgical site infection | Surgical site infection | Overall |
|---|---|---|---|
| ( | ( | ( | |
| Albumin quantity (bottle) | 0.843 ± 2.17 | 1.28 ± 2.63 | 0.93 ± 2.27 |
| Surgical approach | |||
| Anterior | 199 (63%) | 42 (55%) | 241 (61%) |
| Posterior | 114 (36%) | 32 (42%) | 146 (37%) |
| Combined anterior and posterior | 5 (2%) | 2 (3%) | 7 (2%) |
| Titanium cage | |||
| No | 174 (55%) | 43 (57%) | 217 (55%) |
| Yes | 144 (45%) | 33 (43%) | 177 (45%) |
| Internal fixation | |||
| No | 39 (12%) | 12 (16%) | 51 (13%) |
| Yes | 279 (88%) | 64 (84%) | 343 (87%) |
| Blood transfusion | |||
| No | 221 (69%) | 49 (64%) | 270 (69%) |
| Yes | 97 (31%) | 27 (36%) | 124 (31%) |
| Local streptomycin | |||
| No | 44 (14%) | 7 (9%) | 51 (13%) |
| Yes | 274 (86%) | 69 (91%) | 343 (87%) |
| Operation time (min) | 126 ± 41.9 | 166 ± 87.3 | 133.68 ± 55.81 |
| Bleeding volume (mL) | 374 ± 367 | 503 ± 499 | 398.81 ± 398.76 |
| Red blood cell transfusion (U) | 0.893 ± 2.08 | 6.38 ± 45.8 | 1.95 ± 20.21 |
| Drainage (mL) | 329 ± 274 | 396 ± 357 | 342.29 ± 292.50 |
| Abscess | |||
| No | 85 (27%) | 10 (13%) | 95 (24%) |
| Yes | 233 (73%) | 66 (87%) | 299 (76%) |
| Kyphosis | |||
| No | 170 (53%) | 39 (51%) | 209 (53%) |
| Yes | 148 (47%) | 37 (49%) | 185 (47%) |
| Incision length (cm) | 9.40 ± 3.20 | 11.0 ± 4.99 | 9.72 ± 3.66 |
| Lesion segment | 2.12 ± 0.702 | 2.47 ± 1.14 | 2.19 ± 0.82 |
FIG. 1.Radiographic examination of the patient with surgical site infection. (A) Pre-operative radiograph in the posterior-anterior position. (B) Pre-operative radiograph in the lateral position. (C) Post-operative radiograph in the posterior-anterior position. (D) Post-operative radiograph in the lateral position.
FIG. 4.The construction of the least absolute shrinkage and selection operator (LASSO) model for selecting the optimal parameters (λ) and drawing the relation graph between binomial deviance and log (λ).
FIG. 5.The features with non-zero coefficients selected using optimal lambda.
Multivariate Logistic Regression Analysis
| OR | 95%CI |
| |
|---|---|---|---|
| Albumin | 0.872 | 0.804–0.942 | 0.001[ |
| Operation time | 1.013 | 1.007–1.019 | < 0.001[ |
| Incision length | 1.104 | 1.014–1.208 | 0.025** |
| Lesion segment | 1.477 | 1.019–2.166 | 0.042** |
| Medical history | 0.960 | 0.917–0.994 | 0.047** |
| Blood urea | 1.206 | 1.042–1.406 | 0.012** |
OR = odds ratio; CI = confidence interval.
p < 0.01; **p < 0.05.
FIG. 6.The parameters, including albumin, blood urea, operation time, incision length, medical history, and lesion segment, analyzed by the receiver operating characteristic (ROC) curve.
The AUC for the Parameters Was Calculated Using the ROC Curve
| AUC | 95%CI |
| |
|---|---|---|---|
| Albumin | 0.405 | 0.336–0.473 | 0.010[ |
| Operation time | 0.620 | 0.544–0.697 | 0.001[ |
| Incision length | 0.595 | 0.518–0.571 | 0.010[ |
| Lesion segment | 0.581 | 0.507–0.656 | 0.028[ |
| Medical history | 0.441 | 0.370–0.512 | 0.112 |
| Blood urea | 0.542 | 0.471–0.613 | 0.260 |
AUC = area under the curve; ROC = receiver operating characteristic curve.
p < 0.05; **p < 0.01.
FIG. 7.Comparison of parameters between the surgical site and non-surgical site infection group. (A) Albumin. (B) Operation time. (C) Lesion segment. (D) Incision length. Note: *p < 0.05. **p < 0.01.
FIG. 8.The nomogram for predicting the risk of surgical site infection.
FIG. 9.Calibration curves for the nomogram of surgical site infection.
FIG. 10.Receiver operating characteristic (ROC) curve for the predictive nomogram. The area under the curve (AUC) value of the nomogram scoring system for predicting surgical site infection was 0.69.
FIG. 11.The nomogram of the decision curve analysis (DCA) and the net benefit of the model ranging between 0.01 and 0.99.